from 31 Mar 2019 to 31 Dec 2025

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Dianthus Therapeutics, Inc. /DE/ quarterly Debt-to-equity in % history and change rate from 31 Mar 2019 to 31 Dec 2025.
Dianthus Therapeutics, Inc. /DE/ Debt-to-equity for the quarter ending 31 Dec 2025 was 6.7%, a 62% increase year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Change (%)

Dianthus Therapeutics, Inc. /DE/ Quarterly Debt-to-equity (%)

Period	Value	YoY Chg	Change %	Date
Q4 2025	6.7%	+2.6%	+62%	31 Dec 2025
Q3 2025	6.2%	+2.4%	+63%	30 Sep 2025
Q2 2025	6.1%	+1.9%	+46%	30 Jun 2025
Q1 2025	5%	-0.85%	-15%	31 Mar 2025
Q4 2024	4.1%	-11%	-72%	31 Dec 2024
Q3 2024	3.8%	-151%	-98%	30 Sep 2024
Q2 2024	4.2%	+35%		30 Jun 2024
Q1 2024	5.8%	+66%		31 Mar 2024
Q4 2023	15%	+117%		31 Dec 2023
Q3 2023	154%	+281%		30 Sep 2023
Q2 2023	-31%	-116%	-137%	30 Jun 2023
Q1 2023	-60%	-84%	-358%	31 Mar 2023
Q4 2022	-103%	-114%	-1043%	31 Dec 2022
Q3 2022	-126%	-139%	-1070%	30 Sep 2022
Q2 2022	85%	+71%	+519%	30 Jun 2022
Q1 2022	23%	+8.9%	+62%	31 Mar 2022
Q4 2021	11%	-4.5%	-29%	31 Dec 2021
Q3 2021	13%	+0.95%	+7.9%	30 Sep 2021
Q2 2021	14%	+1.8%	+15%	30 Jun 2021
Q1 2021	14%	+2.8%	+24%	31 Mar 2021
Q4 2020	15%	+4.7%	+44%	31 Dec 2020
Q3 2020	12%	+2.9%	+31%	30 Sep 2020
Q2 2020	12%	+3.2%	+36%	30 Jun 2020
Q1 2020	12%	+4%	+53%	31 Mar 2020
Q4 2019	11%			31 Dec 2019
Q3 2019	9.2%			30 Sep 2019
Q2 2019	8.8%			30 Jun 2019
Q1 2019	7.6%			31 Mar 2019

* An asterisk sign (*) next to the value indicates that the value is likely invalid.